You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Trump on Cancer-Ridden Biden: ‘I Really Don't Feel Sorry for Him'
- 2. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 3. Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
- 4. UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
- 5. ASCO25: Pfizer's Braftovi combo boasts 47% drop in disease progression in mCRC
- 6. Gut bacteria may hold key to unlocking better cancer treatment
- 7. ASCO 2025: Combination of encorafenib and cetuximab with chemotherapy helps some patients with advanced colorectal cancer live longer
- 8. ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
- 9. Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
- 10. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
Last updated at 20:49 GMT
Hot News Makers
Health/Pharma Companies
-
482317.41
-
114155.07
-
109385.13
-
99525.53
-
86123.39
-
81766.84
-
75887.97
-
41463.09
-
29150.73
-
21772.79
Drugs, Treatments, Trials
-
384641.22
-
37069.30
-
17631.10
-
14091.36
-
9663.68
-
8304.01
-
5143.16
-
4914.76
-
4393.71
-
3923.04
Last updated at 20:10 GMT
